Former Nebraska Sen. Ben Sasse credited the drug with extending his life after his terminal cancer diagnosis.

Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.

The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.

RAS inhibitor daraxonrasib doubled survival outcomes in second-line trial